Literature DB >> 19102792

Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease.

T R Callaway1, T S Edrington, R C Anderson, R B Harvey, K J Genovese, C N Kennedy, D W Venn, D J Nisbet.   

Abstract

The microbial population of the intestinal tract is a complex natural resource that can be utilized in an effort to reduce the impact of pathogenic bacteria that affect animal production and efficiency, as well as the safety of food products. Strategies have been devised to reduce the populations of food-borne pathogenic bacteria in animals at the on-farm stage. Many of these techniques rely on harnessing the natural competitive nature of bacteria to eliminate pathogens that negatively impact animal production or food safety. Thus feed products that are classified as probiotics, prebiotics and competitive exclusion cultures have been utilized as pathogen reduction strategies in food animals with varying degrees of success. The efficacy of these products is often due to specific microbial ecological factors that alter the competitive pressures experienced by the microbial population of the gut. A few products have been shown to be effective under field conditions and many have shown indications of effectiveness under experimental conditions and as a result probiotic products are widely used in all animal species and nearly all production systems. This review explores the ecology behind the efficacy of these products against pathogens found in food animals, including those that enter the food chain and impact human consumers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19102792     DOI: 10.1017/S1466252308001540

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  43 in total

1.  Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus.

Authors:  Joakim M Andersen; Rodolphe Barrangou; Maher Abou Hachem; Sampo Lahtinen; Yong Jun Goh; Birte Svensson; Todd R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Oral treatment of chickens with lactobacilli influences elicitation of immune responses.

Authors:  Jennifer T Brisbin; Joshua Gong; Shahriar Orouji; Jessica Esufali; Amirul I Mallick; Payvand Parvizi; Patricia E Shewen; Shayan Sharif
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

Review 3.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

4.  Probiotic therapy - recruiting old friends to fight new foes.

Authors:  Roy D Sleator
Journal:  Gut Pathog       Date:  2010-06-25       Impact factor: 4.181

Review 5.  Microbial enzymatic production and applications of short-chain fructooligosaccharides and inulooligosaccharides: recent advances and current perspectives.

Authors:  T Mutanda; M P Mokoena; A O Olaniran; B S Wilhelmi; C G Whiteley
Journal:  J Ind Microbiol Biotechnol       Date:  2014-05-03       Impact factor: 3.346

6.  Bacillus subtilis Strain DSM 29784 Modulates the Cecal Microbiome, Concentration of Short-Chain Fatty Acids, and Apparent Retention of Dietary Components in Shaver White Chickens during Grower, Developer, and Laying Phases.

Authors:  Mohamed Neijat; Jemaneh Habtewold; Rob B Shirley; Alissa Welsher; James Barton; Pascal Thiery; Elijah Kiarie
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

7.  Oral administration of Lactobacillus reuteri expressing a 3D8 single-chain variable fragment (scFv) enhances chicken growth and conserves immune homeostasis.

Authors:  Shanmugam Sureshkumar; Sun Keun Jung; Dongjun Kim; Keon Bong Oh; Hyeon Yang; Hwi Cheul Lee; Jo Yong Jin; Lee Hae Sun; Sukchan Lee; Sung June Byun
Journal:  3 Biotech       Date:  2019-06-24       Impact factor: 2.406

8.  Survival of Escherichia coli O157:H7 on cattle hides.

Authors:  Terrance M Arthur; Xiangwu Nou; Norasak Kalchayanand; Joseph M Bosilevac; Tommy Wheeler; Mohammad Koohmaraie
Journal:  Appl Environ Microbiol       Date:  2011-03-11       Impact factor: 4.792

Review 9.  Are There Effective Intervention Measures in Broiler Production against the ESBL/AmpC Producer Escherichia coli?

Authors:  Evelyne Becker; Michaela Projahn; Elke Burow; Annemarie Käsbohrer
Journal:  Pathogens       Date:  2021-05-15

10.  The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora.

Authors:  Ali Riza Cenk Celebi; Ozlem Onerci Celebi
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.